Mycophenolate Mofetil
Selectively inhibits T and B cell proliferation. It is often preferred over older immunosuppressants due to a better safety profile regarding bone marrow.
Dosage by Body Weight
Pediatric dose: 600 mg/m² twice daily. Max 2 grams per day.
- Body Weight
- 15-25 kg
- Dose
- 250 mg to 500 mg
- Frequency
- Twice daily
- Tracking Notes
- Do not open or crush capsules (teratogenic/irritant).
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| 15-25 kg | 250 mg to 500 mg | Twice daily | Do not open or crush capsules (teratogenic/irritant). |
Formulation
Purpose
Prevention of organ rejection in transplant patients and treatment of Lupus Nephritis.
Generic Name
MMFBranded Drug Names
Mycophenolate Mofetil is listed as a generic drug name. Common branded medicines that may contain the same active ingredient include:
Scheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.
Alternatives
Safety Advice
Alcohol
CAUTIONMycophenolate Mofetil: Alcohol can increase liver strain, stomach irritation, or immune-related complications. Avoid alcohol unless your specialist allows it.
Pregnancy
CAUTIONMycophenolate Mofetil: Use in pregnancy only under specialist advice because immune, cancer, or transplant treatment requires careful risk assessment.
Breast Feeding
CAUTIONMycophenolate Mofetil: Breastfeeding may not be recommended with some immunosuppressive or chemotherapy medicines. Follow specialist advice.
Driving
CAUTIONMycophenolate Mofetil: May cause dizziness, fatigue, nausea, or weakness. Avoid driving if affected.
Liver
CAUTIONMycophenolate Mofetil: Can affect liver function and usually requires regular blood tests. Use only with specialist monitoring.
Kidney
CAUTIONMycophenolate Mofetil: Kidney function may need close monitoring, particularly with calcineurin inhibitors or high-risk regimens.